NCT01081639View on ClinicalTrials.gov

To Evaluate the Convenience, Safety and Efficacy of Follitropin Alfa Liquid Pen Compared With Follitropin Beta Liquid Pen

PHASE3CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions
InfertilityOvulation Induction
Interventions
DRUG

Follitropin alfa liquid formulation

Follitropin alfa (Gonal-f) liquid pen (300, 450 and 900 IU) was applied by subcutaneous (sc) administration. Regimen of recombinant FSH-stimulation followed the standard protocol of the IVF-center

DRUG

Follitropin beta liquid formulation

Follitropin beta (Puregon) liquid cartridge (300 and 600 IU) used with the Pen was applied by sc administration. Regimen of recombinant FSH-stimulation followed the standard protocol of the IVF-center

All Listed Sponsors
collaborator

Merck Serono GmbH, Germany

INDUSTRY

lead

Merck KGaA, Darmstadt, Germany

INDUSTRY

NCT01081639 - To Evaluate the Convenience, Safety and Efficacy of Follitropin Alfa Liquid Pen Compared With Follitropin Beta Liquid Pen | Biotech Hunter | Biotech Hunter